The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections-Reference-Cited by-同舟云学术

The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections

Published:2014-05 Issue:5 Volume:121 Page:1092-1101
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Funder

UCL Institute of Ophthalmology, University College London

Novartis Pharmaceuticals UK Limited

Publisher

Elsevier BV

Subject

Ophthalmology

Reference27 articles.

1. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

2. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

3. National Institute for Health and Clinical Excellence. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration. NICE technology appraisal guidance 155. Last modified May 2012. Available at: http://www.nice.org.uk/nicemedia/live/12057/41719/41719.pdf. Accessed August 7, 2013.

4. Ranibizumab and bevacizumab for neovascular age-related macular degeneration;CATT Research Group;N Engl J Med,2011

5. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results;Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group;Ophthalmology,2012

Cited by 255 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Anti-VEGF Treatment and Patient Characteristics on Vision Outcomes in Neovascular Age-related Macular Degeneration;Ophthalmology Science;2024-03

2. LONG-TERM USE OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION;Retina;2024-02

3. Clinical Trials and Future Outlooks of the Port Delivery System with Ranibizumab: A Narrative Review;Ophthalmology and Therapy;2023-12-06

4. From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema;Progress in Retinal and Eye Research;2023-11

5. Optimizing Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration: the Potential Value of Sustained Anti-VEGF Therapy;Ophthalmic Surgery, Lasers and Imaging Retina;2023-11